Cancer Therapy Related News
Defence work with City of Hope in filing a new AccuTOX cancer programme
Defence Therapeutics has teamed up with City of Hope to submit an application for the clinical trialling of their AccuTOX TM technology.
The Canadian biopharmaceutical...
Defence Therapeutics has US patent accepted for Accum
Defence Therapeutics Inc, a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies including Antibody Drug Conjugate...
A new biomarker can measure CAR-T cell therapy response
Researchers have discovered a potent biomarker for clinical responses to CAR-T cell therapy that could improve lymphoma treatment.
The findings from MedUni Vienna could provide...
Lung cancer immunotherapy side effects prevented with genetic discovery
Scientists at Edith Cowan University have made a groundbreaking genetic discovery that may eliminate side effects from lung cancer immunotherapy.
Of all types of cancer, lung...
Alpelisib becomes 100th fast tracked NHS cancer drug
Alpelisib – a life-extending drug for patients with advanced breast cancer – has become the 100th fast-tracked cancer drug on the NHS and will...
Drug treatment for uveal melanoma shows exciting results
Effective drug treatment for a rare type of eye cancer known as uveal melanoma (UM) may soon be on the horizon, thanks to a...
Scientists identify a range of new bladder cancer treatments
A study performed at MedUni Vienna has discovered hundreds of new potential bladder cancer treatments, with one commonly used drug demonstrating effectiveness against two...
New approach shortens manufacturing time for CAR T cell therapy
Researchers from the University of Pennsylvania (Penn) have developed a new method to cut manufacturing time for CAR T cell therapy.
The cell manufacturing process...
Combinatorial glioblastoma treatment destroys incurable brain tumour
Novel research has devised an innovative glioblastoma treatment, finding that combining two existing therapies can eliminate fatal brain tumours.
The endeavour, led by researchers at...
Utilising light therapy to enhance healing from cancer radiation treatment
The implementation of light therapy potentially increases skin healing from damage caused by cancer radiation therapy by up to 50%.
In a new study pioneered...
Enhancing cancer patient lives through cancer treatment optimisation
Denis Lacombe, CEO of the EORTC, explores the challenges facing cancer research, and how the organisation is working to optimise cancer treatment.
Cancer is the...
BRCA2 gene investigation may help to design targeted cancer treatment
Danish researchers have potentially made a groundbreaking advancement in developing an effective targeted therapy for cancer, identifying the pivotal role that the BRCA2 gene...
Defence Therapeutics embark on next stage of breast cancer treatment development
In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
Improving outcomes for children following radiation therapy
A team of experts from around the world has teamed up to improve clinical outcomes for children with cancer following radiation therapy.
Radiation therapy has...
Reducing resistance to cancer immunotherapy with groundbreaking lipid
A team of Japanese scientists has potentially discovered an innovative method to reduce a patient’s resistance to cancer immunotherapy.
The team, based at the Hokkaido...
Improving leukaemia therapy through targeted treatment
Researchers at the University of Basel have demonstrated an effective method of targeted treatment to enhance leukaemia therapy.
Stem-like T cells may enhance immunotherapy cancer treatment
A team of researchers has made a potentially groundbreaking discovery in cancer treatment, identifying that stem-like T cells may be proficient in fighting against...
Cancer treatment could be improved by new causal understanding
New insights on why identical mutations cause different types of cancer could lead to improvements in targeted treatment, researchers say.
Researchers at the German Cancer...
Collaboration established for the optimisation of cancer therapeutic
Defence Therapeutics Inc. has established a collaboration with the HUS Comprehensive Cancer Center at Helsinki, Finland, for the optimisation of Defence’s Accum-T-DM1 ADC Therapeutic.
Defence...
Positive patient reported outcomes for prostate cancer therapy
Results from the Phase III TITAN study final analysis have confirmed the survival benefit achieved with the addition of apalutamide to androgen deprivation therapy...
